You can buy or sell Medtronic and other stocks, options, ETFs, and crypto commission-free!
Medtronic plc, also called Medtronic, is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. Read More It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.
52 Week High
52 Week Low
Medtronic plc CEO Omar Ishrak on Q4 2019 Results - Earnings Call Transcript
Medtronic plc (NYSE:MDT) Q4 2019 Earnings Conference Call May 23, 2019 8:00 AM ET Company Participants Ryan Weispfenning - VP, IR Omar Ishrak - Chairman and CEO Karen L. Parkhill - EVP and CFO Hooman Hakami - EVP and President, Diabetes Group Michael J. Coyle - EVP and President, CVG Bob White - EVP and President, MITG Geoffrey S. Martha - EVP and Group President, Restorative Therapies Group Conference Call Participants Bob Hopkins - Bank of America David Lewis - Morgan Stanley Vijay Kumar - Eve...
Strong surgical instrument sales fuel Medtronic's upbeat forecast
(Reuters) - Medtronic Plc reported quarterly profit ahead of estimates on strong demand for its surgical instruments and forecast better-than-expected 2020 earnings on Thursday, sending shares of the medical device maker up nearly 3%. The company has been building its minimally invasive and robotic surgery device businesses through new launches and acquisitions to ease the impact of rising competition it faces at its top-earning cardiac and vascular unit. There had been growing concerns among investors af...
Medtronic Rises 3%
Investing.com - Medtronic (NYSE:MDT) rose by 3.01% to trade at $91.42 by 15:11 (19:11 GMT) on Thursday on the NYSE exchange. The volume of Medtronic shares traded since the start of the session was 9.35M. Medtronic has traded in a range of $90.12 to $91.47 on the day. The stock has traded at $91.4600 at its highest and $86.7600 at its lowest during the past seven days. Scroll to continue with content Ad Related Articles Mastercard Falls 3% Facebook Falls 3% Exclusive: JPMorgan cuts ties with OxyConti...
$1.47 per share
$1.54 per share